BCL2 and hepatocellular carcinoma: Jiang et al. found that it can inhibit tumor growth in hepatocellular carcinoma (HCC) cell lines (SMMC-7721, Bel-7402), induce Go/G1 cell cycle arrest, and induce apoptosis through FOXO1 activation and increase of Bax to Bcl-2 ratio [35].